FR3096893B1 - Composition a base d’extrait de jeunes pousses et utilisation pour la prevention et le traitement des maladies liees au vieillissement - Google Patents

Composition a base d’extrait de jeunes pousses et utilisation pour la prevention et le traitement des maladies liees au vieillissement Download PDF

Info

Publication number
FR3096893B1
FR3096893B1 FR1906032A FR1906032A FR3096893B1 FR 3096893 B1 FR3096893 B1 FR 3096893B1 FR 1906032 A FR1906032 A FR 1906032A FR 1906032 A FR1906032 A FR 1906032A FR 3096893 B1 FR3096893 B1 FR 3096893B1
Authority
FR
France
Prior art keywords
extract
young shoots
aging
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1906032A
Other languages
English (en)
Other versions
FR3096893A1 (fr
Inventor
Emeline Denuet
Michel Dumoulin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Exact
Original Assignee
Laboratoire Exact
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Exact filed Critical Laboratoire Exact
Priority to FR1906032A priority Critical patent/FR3096893B1/fr
Publication of FR3096893A1 publication Critical patent/FR3096893A1/fr
Application granted granted Critical
Publication of FR3096893B1 publication Critical patent/FR3096893B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Psychology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L’invention concerne une composition comprenant au moins un extrait de jeunes pousses et/ou de bourgeons d’une plante ou d’un arbre, pour son utilisation dans la prévention et/ou le traitement de maladies liées au vieillissement chez l’être humain ou l’animal. L’invention a également pour objet une composition particulière adaptée à une telle utilisation, à savoir une composition comprenant :- au moins deux extraits différents de jeunes pousses de ronces et/ou de framboisier, et/ou- au moins un extrait de jeunes pousses et/ou de bourgeons de plantes ou d’arbres choisis parmi l’aulne, le frêne, le chêne, l’ortie et leurs mélanges.
FR1906032A 2019-06-06 2019-06-06 Composition a base d’extrait de jeunes pousses et utilisation pour la prevention et le traitement des maladies liees au vieillissement Active FR3096893B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1906032A FR3096893B1 (fr) 2019-06-06 2019-06-06 Composition a base d’extrait de jeunes pousses et utilisation pour la prevention et le traitement des maladies liees au vieillissement

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1906032A FR3096893B1 (fr) 2019-06-06 2019-06-06 Composition a base d’extrait de jeunes pousses et utilisation pour la prevention et le traitement des maladies liees au vieillissement
FR1906032 2019-06-06

Publications (2)

Publication Number Publication Date
FR3096893A1 FR3096893A1 (fr) 2020-12-11
FR3096893B1 true FR3096893B1 (fr) 2022-08-05

Family

ID=68138386

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1906032A Active FR3096893B1 (fr) 2019-06-06 2019-06-06 Composition a base d’extrait de jeunes pousses et utilisation pour la prevention et le traitement des maladies liees au vieillissement

Country Status (1)

Country Link
FR (1) FR3096893B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3132435A1 (fr) * 2022-02-04 2023-08-11 Charlois Cosmétiques Extrait de bourgeons de chêne du genre Quercus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19838462A1 (de) * 1998-08-25 2000-03-02 Wolfgang Feige Verfahren zur Herstellung einer aseptischen Flüssigkeit
FR2791893B1 (fr) * 1999-04-12 2001-05-25 Prod Hyg Lab Compositions cosmetiques, dermopharmaceutiques, alimentaires ou agricoles a activite nutritionnelle, amincissante, anti-inflammatoire, anti-oxydante, anti-acnee, contenant un extrait de pepin de pamplemousse
US20060024385A1 (en) * 2004-07-27 2006-02-02 Pedersen Mark A Metabolic capacity enhancing compositions and methods for use in a mammal
WO2007024901A1 (fr) * 2005-08-23 2007-03-01 Access Business Group International Llc Modulatoeurs de cytokine et procedes d'utilisation associes
US10543242B2 (en) * 2014-12-11 2020-01-28 Felician Stancioiu Composition for the treatment of joint conditions

Also Published As

Publication number Publication date
FR3096893A1 (fr) 2020-12-11

Similar Documents

Publication Publication Date Title
MA41558B1 (fr) Compositions d'allergènes mélangés et leurs procédés d'utilisation
CY1111661T1 (el) Μυκητοκτονες ενωσεις
FR3076997B1 (fr) Extrait obtenu a partir de plusieurs plantes pour son utilisation dans la prevention et/ou le traitement des maladies chroniques inflammatoires de l'intestin
TN2017000081A1 (fr) Extrait d'algues concentré, procédé de préparation et ses utilisations en agriculture.
MA25393A1 (fr) Compositions pesticides et/ou regulatrices de la croissance des plantes.
Aneesa Beneficial effects of neem oil-An updated review
EP1095660A3 (fr) Formulation thérapeutique contenant du terpinène-4-ol et des plantes médicinales
FR3096893B1 (fr) Composition a base d’extrait de jeunes pousses et utilisation pour la prevention et le traitement des maladies liees au vieillissement
Meena et al. Application of Moringa oleifera in Dentistry
ATE381936T1 (de) Zusammensetzung mit niemöl und ölextrakt aus johanniskraut mit heilenden, abweisenden und bioziden eigenschaften zur behandlung äusserer wunden
BRPI0418293A (pt) composição compreendendo um extrato aquoso de folhas de videira de uvas vermelhas e um diurético para o tratamento de insuficiências venosas crÈnicas
WO2012131117A8 (fr) Utilisation d'antifongiques naturels pour prévenir l'infection de lésions, de greffes et des plaies d'élagage dans des plantes ligneuses par des champignons phytopathogènes
WO2020232181A8 (fr) Compositions comprenant des extraits de plantes et des huiles et méthodes de traitement associées et leur préparation
CN107865006A (zh) 一种果树杀虫剂
EA201790131A1 (ru) Жидкие распределяющиеся композиции с антиэктопаразитарной активностью, способ борьбы с эктопаразитами и их применение в медицине и ветеринарии, а также в сельском хозяйстве, садоводстве и/или растениеводстве
FR3059236B1 (fr) Extraits de plantes du genre tagetes et leurs utilisations
CA3155701A1 (fr) Utilisation de resine de pin pour le traitement et la prevention de la douleur musculaire et de la douleur articulaire du pied
FR2383606A1 (fr) Compositions insecticides et acaricides a base de derives de ferrocene et d'un ou plusieurs autres pesticides
MX2022003528A (es) Compuestos farmacéuticos y métodos de uso.
GB2584599A (en) Alcohol gels for the treatment of athletes foot
Dhiman A Review on Medicinal uses of Moringa oleifera
FR3085847B1 (fr) Principe actif cosmetique obtenu a partir de l'albumen du fruit de cocos nucifera et utilisations cosmetiques
DE202017004342U1 (de) Anti-Parasitenöl, unter Verwendung von Cistus incanus mit Kokosöl
DE602004003105D1 (de) Mittel gegen Lausbefall
Meena et al. Pharma Research

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20201211

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5